Status:
COMPLETED
Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs
Lead Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Conditions:
Sars-CoV2
Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the novel coronavirus disease 2019 (COVID-19) pandemic. Among COVID-19 complications, in-hospital cardiac arrest (IHCA) ...
Detailed Description
Retrospective and prospective multicentric observational registry in French intensive care units (ICU) including all consecutive adult patients admitted in ICU with a documented SARS-CoV-2 disease : ...
Eligibility Criteria
Inclusion
- Patients admitted in intensive care unit with a documented SARS-CoV-2 disease
- For an out-of-hospital or an in-hospital cardiac arrest
- Or an in-hospital cardiac arrest
- Or presenting an unexpected in-intensive care unit cardiac arrest
Exclusion
- Age under 18 y.o
- Expected in-intensive care unit cardiac arrest related to withdrawal of life sustaining therapies.
- Withdrawal of patient or next-of-kin informed consent
Key Trial Info
Start Date :
May 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT04373759
Start Date
May 2 2020
End Date
September 30 2020
Last Update
October 13 2022
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Caen
Caen, Calvados, France, 14000
2
Hôpital Privé St Martin
Caen, Calvados, France, 14000
3
CH Angoulème
Angoulême, Charente, France, 16959
4
CH Brive
Brive-la-Gaillarde, Corrèze, France, 19100